Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paridhi Sukheja

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 25, 2025
Novel isoxazole thiophene-containing compounds active against Mycobacterium tuberculosisGabrielle Martinez, Kirsten Tolentino, Paridhi Sukheja, et al.
ACS Medicinal Chemistry Letters|December 17, 2025
Design, Synthesis, and Biological Evaluation of Tetrazol-2-yl-acetamides as Novel Antitubercular AgentsBaiyuan Yang, Paridhi Sukheja, Jasmine Webb, et al.
Bioorganic & Medicinal Chemistry Letters|December 24, 2023
Synthesis and structure-activity relationships of aryl fluorosulfate-based inhibitors as novel antitubercular agentsBaiyuan Yang, Paridhi Sukheja, Bo Qin, et al.
Mbio|February 16, 2017
A Novel Small-Molecule Inhibitor of the <i>Mycobacterium tuberculosis</i> Demethylmenaquinone Methyltransferase MenG Is Bactericidal to Both Growing and Nutritionally Deprived Persister CellsParidhi Sukheja, Pradeep Kumar, Nisha Mittal, et al.
The Journal of Biological Chemistry|December 10, 2025
Inhibition of de novo fatty acid synthesis in Mycobacterium tuberculosisEmma K Roszkowski, Sarita Charap, Christine R Montague, et al.
Journal of Medicinal Chemistry|March 4, 2025
Evolution of Small Molecule Inhibitors of <i>Mycobacterium tuberculosis</i> Menaquinone BiosynthesisPankaj Sharma, Quan Jiang, Shao-Gang Li, et al.
EMBO Molecular Medicine|April 7, 2026
Integrating chemical, genetic, and feasibility assessments for anti-tubercular target validationDirk Schnappinger, Steven J Berthel, Helena I M Boshoff, et al.
Cell Chemical Biology|March 21, 2020
A Preclinical Candidate Targeting Mycobacterium tuberculosis KasADaigo Inoyama, Divya Awasthi, Glenn C Capodagli, et al.
Mbio|December 20, 2018
Synergistic Lethality of a Binary Inhibitor of Mycobacterium tuberculosis KasAPradeep Kumar, Glenn C Capodagli, Divya Awasthi, et al.
Nature|July 31, 2025
SuFEx-based antitubercular compound irreversibly inhibits Pks13Inna V Krieger, Paridhi Sukheja, Baiyuan Yang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|January 25, 2025
Novel isoxazole thiophene-containing compounds active against Mycobacterium tuberculosisGabrielle Martinez, Kirsten Tolentino, Paridhi Sukheja, et al.
ACS Medicinal Chemistry Letters|December 17, 2025
Design, Synthesis, and Biological Evaluation of Tetrazol-2-yl-acetamides as Novel Antitubercular AgentsBaiyuan Yang, Paridhi Sukheja, Jasmine Webb, et al.
Bioorganic & Medicinal Chemistry Letters|December 24, 2023
Synthesis and structure-activity relationships of aryl fluorosulfate-based inhibitors as novel antitubercular agentsBaiyuan Yang, Paridhi Sukheja, Bo Qin, et al.
Mbio|February 16, 2017
A Novel Small-Molecule Inhibitor of the <i>Mycobacterium tuberculosis</i> Demethylmenaquinone Methyltransferase MenG Is Bactericidal to Both Growing and Nutritionally Deprived Persister CellsParidhi Sukheja, Pradeep Kumar, Nisha Mittal, et al.
The Journal of Biological Chemistry|December 10, 2025
Inhibition of de novo fatty acid synthesis in Mycobacterium tuberculosisEmma K Roszkowski, Sarita Charap, Christine R Montague, et al.
Journal of Medicinal Chemistry|March 4, 2025
Evolution of Small Molecule Inhibitors of <i>Mycobacterium tuberculosis</i> Menaquinone BiosynthesisPankaj Sharma, Quan Jiang, Shao-Gang Li, et al.
EMBO Molecular Medicine|April 7, 2026
Integrating chemical, genetic, and feasibility assessments for anti-tubercular target validationDirk Schnappinger, Steven J Berthel, Helena I M Boshoff, et al.
Cell Chemical Biology|March 21, 2020
A Preclinical Candidate Targeting Mycobacterium tuberculosis KasADaigo Inoyama, Divya Awasthi, Glenn C Capodagli, et al.
Mbio|December 20, 2018
Synergistic Lethality of a Binary Inhibitor of Mycobacterium tuberculosis KasAPradeep Kumar, Glenn C Capodagli, Divya Awasthi, et al.
Nature|July 31, 2025
SuFEx-based antitubercular compound irreversibly inhibits Pks13Inna V Krieger, Paridhi Sukheja, Baiyuan Yang, et al.
Pageof 1